SCHEMBL11274971

SCHEMBL11274971

CCOC(=O)CC[C@H](NC(CCc1ccccc1)C(=O)O)C(=O)N1CCC[C@H]1C(=O)OCC

nearest known ligand 0.61

Predicted protein targets (top 10)

geneUniProtsupporting neighboursconfidence
▸ ACE P12821 7/20 0.61
▸ LMNA P02545 1/20 0.60
▸ SMN1; SMN2 Q16637 1/20 0.56
▸ ALDH1A1 P00352 2/20 0.47
▸ FKBP1A P62942 4/20 0.46
▸ NPC1 O15118 1/20 0.45
▸ CYP3A4 P08684 1/20 0.45
▸ CYP2D6 P10635 1/20 0.45
▸ CYP2C9 P11712 1/20 0.45
▸ CYP2C19 P33261 1/20 0.45

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL11259353 0.94 ACE (0.68) ACELMNASMN1; SMN2ALDH1A1NPC1
SCHEMBL11292868 0.94 ACE (0.69) ACELMNASMN1; SMN2CYP3A4
SCHEMBL3126925 0.88 ACE (0.80) ACELMNASMN1; SMN2
Enalaprilat Anhydrous SCHEMBL7258975 0.83 ACE (0.88) ACELMNASMN1; SMN2CYP3A4
SCHEMBL24506200 0.82 ACE (0.77) ACELMNASMN1; SMN2
SCHEMBL11262743 0.82 ACE (0.77) ACELMNASMN1; SMN2
SCHEMBL11267471 0.82 ACE (0.77) ACELMNASMN1; SMN2
SCHEMBL11262921 0.82 ACE (0.78) ACELMNASMN1; SMN2CYP3A4
SCHEMBL11267866 0.82 ACE (0.78) ACELMNASMN1; SMN2CYP3A4
SCHEMBL7324222 0.82 ACE (0.87) ACELMNASMN1; SMN2CYP3A4

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0049506-A1 N-carboxyalkyl dipeptides, a process for preparing and a pharmaceutical composition comprising the same MERCK & CO. INC. (US) 1982-04-14 — — EP disclosed
Send feedback